VFA
CDMO

Virtus Fund Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Virtus Fund Advisers’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,331
Closed -$31.4K – 117
2023
Q3 		$31.4K Hold
3,331
– – 0.22% 70
2023
Q2 		$46.5K Hold
3,331
– – 0.33% 53
2023
Q1 		$62.5K Buy
+3,331
New +$54.7K 0.44% 42
2014
Q3 		– Sell
-2,151
Closed -$28K – 2002
2014
Q2 		$28K Buy
+2,151
New +$27.1K ﹤0.01% 2249

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Virtus Fund Advisers's CDMO Position: Q4 2023 in Review

Virtus Fund Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 3,331 shares — an estimated $31.4K sold.

Virtus Fund Advisers first reported a position in CDMO in Q2 2014 and held it in 4 quarters. The position peaked at $62.5K in Q1 2023. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • Virtus Fund Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Virtus Fund Advisers sold 3,331 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $31.4K.
  • Virtus Fund Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • Virtus Fund Advisers's Avid Bioservices, Inc. Common Stock position peaked at $62.5K in Q1 2023.
  • 174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Virtus Fund Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.